DRAGANFLY INC(NASDAQ:DPRO) stock Fundamental Analysis

Fundamental Rating

Overall DPRO gets a fundamental rating of 2 out of 10. We evaluated DPRO against 66 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of DPRO have multiple concerns. While showing a medium growth rate, DPRO is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

DPRO had negative earnings in the past year.

DPRO had a negative operating cash flow in the past year.

DPRO had negative earnings in each of the past 5 years.

In the past 5 years DPRO always reported negative operating cash flow.

1.2 Ratios

DPRO has a Return On Assets of -156.46%. This is amonst the worse of the industry: DPRO underperforms 95.31% of its industry peers.

DPRO has a worse Return On Equity (-305.99%) than 82.81% of its industry peers.

		Industry Rank	Sector Rank
ROA	-156.46%
ROE	-305.99%
ROIC	N/A

ROA(3y)-170.28%

ROA(5y)-193.62%

ROE(3y)-2029.35%

ROE(5y)-1360.53%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 24.58%, DPRO is in line with its industry, outperforming 48.44% of the companies in the same industry.

DPRO's Gross Margin has declined in the last couple of years.

DPRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	24.58%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-7.91%

GM growth 5Y-14.11%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DPRO does not have a ROIC to compare to the WACC, probably because it is not profitable.

DPRO has more shares outstanding than it did 1 year ago.

The number of shares outstanding for DPRO has been reduced compared to 5 years ago.

DPRO has a worse debt/assets ratio than last year.

2.2 Solvency

DPRO has an Altman-Z score of -18.54. This is a bad value and indicates that DPRO is not financially healthy and even has some risk of bankruptcy.

DPRO has a Altman-Z score of -18.54. This is amonst the worse of the industry: DPRO underperforms 95.31% of its industry peers.

A Debt/Equity ratio of 0.07 indicates that DPRO is not too dependend on debt financing.

DPRO has a Debt to Equity ratio of 0.07. This is amongst the best in the industry. DPRO outperforms 87.50% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	N/A
Altman-Z	-18.54

ROIC/WACCN/A

WACC8.09%

2.3 Liquidity

DPRO has a Current Ratio of 1.94. This is a normal value and indicates that DPRO is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of DPRO (1.94) is comparable to the rest of the industry.

A Quick Ratio of 1.54 indicates that DPRO should not have too much problems paying its short term obligations.

DPRO has a better Quick ratio (1.54) than 62.50% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.94
Quick Ratio	1.54

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DPRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -247.96%.

DPRO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.66%.

The Revenue has been growing by 36.43% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-247.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

Revenue 1Y (TTM)-15.66%

Revenue growth 3Y14.53%

Revenue growth 5Y36.43%

Sales Q2Q%-11.82%

3.2 Future

The Earnings Per Share is expected to decrease by -27.18% on average over the next years. This is quite bad

DPRO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.62% yearly.

EPS Next Y-570.78%

EPS Next 2Y-49.05%

EPS Next 3Y-27.18%

EPS Next 5YN/A

Revenue Next Year-16.58%

Revenue Next 2Y34.21%

Revenue Next 3Y45.62%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DPRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year DPRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

DPRO's earnings are expected to decrease with -27.18% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-49.05%

EPS Next 3Y-27.18%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

DPRO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DRAGANFLY INC

NASDAQ:DPRO (2/21/2025, 8:14:20 PM)

After market: 2.86 +0.06 (+2.14%)

2.8

-0.24 (-7.89%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryAerospace & Defense

Earnings (Last)11-14 2024-11-14/amc

Earnings (Next)03-25 2025-03-25/amc

Inst Owners15.02%

Inst Owner Change798.35%

Ins Owners1.04%

Ins Owner ChangeN/A

Market Cap11.84M

Analysts82.5

Price Target5.03 (79.64%)

Short Float %3.39%

Short Ratio0.47

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)27.44%

Min EPS beat(2)-40.06%

Max EPS beat(2)94.93%

EPS beat(4)3

Avg EPS beat(4)35.67%

Min EPS beat(4)-40.06%

Max EPS beat(4)94.93%

EPS beat(8)4

Avg EPS beat(8)-14.1%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-29.03%

Min Revenue beat(2)-40.03%

Max Revenue beat(2)-18.03%

Revenue beat(4)0

Avg Revenue beat(4)-38.76%

Min Revenue beat(4)-71.67%

Max Revenue beat(4)-18.03%

Revenue beat(8)0

Avg Revenue beat(8)-32.02%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)15.25%

PT rev (3m)-4.82%

EPS NQ rev (1m)16.02%

EPS NQ rev (3m)-1800%

EPS NY rev (1m)28.08%

EPS NY rev (3m)28.08%

Revenue NQ rev (1m)-9.35%

Revenue NQ rev (3m)-21.18%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-12.66%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.87
P/FCF	N/A
P/OCF	N/A
P/B	3.86
P/tB	3.9
EV/EBITDA	N/A

EPS(TTM)-2.4

EYN/A

EPS(NY)-0.92

Fwd EYN/A

FCF(TTM)-2.19

FCFYN/A

OCF(TTM)-2.16

OCFYN/A

SpS0.98

BVpS0.73

TBVpS0.72

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-156.46%
ROE	-305.99%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	24.58%
FCFM	N/A

ROA(3y)-170.28%

ROA(5y)-193.62%

ROE(3y)-2029.35%

ROE(5y)-1360.53%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-7.91%

GM growth 5Y-14.11%

F-Score5

Asset Turnover0.69

Health

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	25.94%
Cap/Sales	2.61%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.94
Quick Ratio	1.54
Altman-Z	-18.54

F-Score5

WACC8.09%

ROIC/WACCN/A

Cap/Depr(3y)56.32%

Cap/Depr(5y)72.3%

Cap/Sales(3y)3.87%

Cap/Sales(5y)3.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-247.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

EPS Next Y-570.78%

EPS Next 2Y-49.05%

EPS Next 3Y-27.18%

EPS Next 5YN/A

Revenue 1Y (TTM)-15.66%

Revenue growth 3Y14.53%

Revenue growth 5Y36.43%

Sales Q2Q%-11.82%

Revenue Next Year-16.58%

Revenue Next 2Y34.21%

Revenue Next 3Y45.62%

Revenue Next 5YN/A

EBIT growth 1Y50.38%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year50.96%

EBIT Next 3Y21.54%

EBIT Next 5YN/A

FCF growth 1Y23.45%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y25.13%

OCF growth 3YN/A

OCF growth 5YN/A

DRAGANFLY INC (DPRO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens